The Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies. The response of the Company is awaited.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The National Stock Exchange has asked JHS Svendgaard Laboratories to clarify why its financial results for the quarter ended 31 December 2025 were not signed by an authorized signatory. This is a query raised under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements, which requires listed companies to file signed and approved financial results. The company has not yet responded to the exchange, and its reply is awaited. The issue appears to be a procedural or compliance lapse rather than a problem with the actual numbers.
For most retail investors this is a minor technical compliance flag and not a sign of financial trouble. However, repeated unsigned filings or a delayed response could attract further regulatory scrutiny and may briefly dent investor confidence.